Search research articles
Contact Us
Filters
Showing results (11-20 of 91) with videos related to
Page
of 10
Sort By:
American Journal of Hypertension
|
September 15, 2023
Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
Eissa Jafari, Rhonda M Cooper-DeHoff, Mark B Effron, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 23, 2013
Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention
Beth L Nordstrom, Jason C Simeone, Zhenxiang Zhao, et al.
Stroke
|
September 6, 2008
Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial
Harold P Adams, Enrique C Leira, James C Torner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 24, 2018
Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study
Homam Ibrahim, Lisa A Kaltenbach, Connie N Hess, et al.
Seminars in Thrombosis and Hemostasis
|
April 25, 2022
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years
John G Rizk, Aashish Gupta, Jose G Lazo, et al.
Journal of the American College of Cardiology
|
January 15, 2016
Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS
Amit P Amin, Tracy Y Wang, Lisa McCoy, et al.
Journal of the American Heart Association
|
February 14, 2018
Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study
Alexander C Fanaroff, Lisa A Kaltenbach, Eric D Peterson, et al.
Current Medical Research and Opinion
|
July 19, 2014
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 9, 2016
Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrel
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
Journal of the American College of Cardiology
|
December 17, 2013
Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)
Dominick J Angiolillo, Nicholas Curzen, Paul Gurbel, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 91) with videos related to
Sort By:
Page
of 10
American Journal of Hypertension
|
September 15, 2023
Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
Eissa Jafari, Rhonda M Cooper-DeHoff, Mark B Effron, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 23, 2013
Adherence and persistence with prasugrel following acute coronary syndrome with percutaneous coronary intervention
Beth L Nordstrom, Jason C Simeone, Zhenxiang Zhao, et al.
Stroke
|
September 6, 2008
Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial
Harold P Adams, Enrique C Leira, James C Torner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 24, 2018
Glycoprotein IIb/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: Insights from the TRANSLATE ACS study
Homam Ibrahim, Lisa A Kaltenbach, Connie N Hess, et al.
Seminars in Thrombosis and Hemostasis
|
April 25, 2022
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years
John G Rizk, Aashish Gupta, Jose G Lazo, et al.
Journal of the American College of Cardiology
|
January 15, 2016
Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS
Amit P Amin, Tracy Y Wang, Lisa McCoy, et al.
Journal of the American Heart Association
|
February 14, 2018
Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study
Alexander C Fanaroff, Lisa A Kaltenbach, Eric D Peterson, et al.
Current Medical Research and Opinion
|
July 19, 2014
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 9, 2016
Comparative resource utilization and costs for patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with clopidogrel or prasugrel
Jay P Bae, Douglas E Faries, Frank R Ernst, et al.
Journal of the American College of Cardiology
|
December 17, 2013
Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)
Dominick J Angiolillo, Nicholas Curzen, Paul Gurbel, et al.
Page
of 10